News & Updates
Filter by Specialty:
Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease
A small open-label study supports the safety and motor performance effectiveness of closed-loop adaptive deep-brain stimulation (aDBS) compared with conventional daily deep-brain stimulation (cDBS) sessions in Parkinson’s disease (PD) patients.
Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease
06 Oct 2021Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.
Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
05 Oct 2021Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis
Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.
Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis
05 Oct 2021Oteseconazole bests fluconazole for vaginal yeast infections
Oteseconazole (VT-1161), a novel investigational fungal CYP51 inhibitor, outdid fluconazole/placebo for managing acute and recurrent* vulvovaginal candidiasis (VVC), according to data from the phase III ultraVIOLET trial.
Oteseconazole bests fluconazole for vaginal yeast infections
05 Oct 2021HCC in SG: NASH aetiology on the rise, curative therapy more accessible
Hepatocellular carcinoma (HCC) in Singapore has changed markedly throughout the last decade, with patients being diagnosed at an increasingly older age and cryptogenic cirrhosis/nonalcoholic steatohepatitis (NASH) becoming a more important aetiology, according to a recent study.